In addition to IL-6, IL-8 has been shown to play significant roles in predicting the efficacy of ICIs in advanced HCC, primarily through its role in promoting resistance via recruitment of myeloid-derived suppressor cells [49,50,51]. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.